483 Samsung Biologics May 2018

483 Samsung Biologics May 2018

Diane Raccasi FDA, Michael Shanks FDA$119.00 - Available Now

FDA investigators audited the Samsung Biologics - Yeonsu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 11 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 11 May 2018
  • Location: Yeonsu, Korea (the Republic of)
  • FEI: 3010479596
Add To Cart